Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI).

Br J Cancer · 2020 · PMC7653959 · PMID 32868898

Europe PMC DOI

hedged sentence

0.3200

closest p · 6.4× alpha

0.3200

boldest claim

The sentences

did not reach statistical significanceP = 0.32not close (p > 0.1)

CPI response rates were somewhat lower among our immunocompetent patients ( n = 42) comparatively, but this did not reach statistical significance (42 versus 31.5%, P = 0.32).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.